Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Rosa M. Nadal Rios, MD, PhD
Associate Professor
University of Washington School of Medicine and Fred Hutchinson Cancer Center in Seattle
Published Articles (1)
Bladder Cancer at ASCO 2026: A New Standard in Non-Muscle Invasive Disease, Intravesical Approaches in Muscle-Invasive Disease, and Three and a Half Years of Enfortumab Vedotin Data
July 14, 2026
Bladder cancer management in 2026 has been transformed at multiple stages of disease: in non-muscle invasive disease by the arrival of immune checkpoint inhibitors added to BCG